Clinical Report: Predictive Model for Lymph Node Metastasis in Stage IA NSCLC

Overview

This study identifies risk factors for lymph node metastasis in clinical stage IA peripheral non-small cell lung cancer (NSCLC) and develops a logistic regression-based nomogram for preoperative risk assessment. The findings highlight the importance of tailored surgical strategies to improve patient outcomes.

Background

Lung cancer is the leading cause of cancer-related mortality globally, with NSCLC comprising a significant majority of cases. Early detection through low-dose computed tomography has increased the identification of clinical stage IA NSCLC, which typically has a low risk of lymph node metastasis. However, 15-20% of these patients may still present with metastases postoperatively, necessitating effective preoperative risk assessment.

Data Highlights

No numerical data available in the provided source material.

Key Findings

• 15-20% of clinical stage IA NSCLC patients may have lymph node metastases postoperatively.
• Risk factors for lymph node metastasis were identified through a retrospective analysis of patients undergoing surgical resection.
• A logistic regression-based nomogram was developed to assist in preoperative risk assessment.
• Subgroup analysis was conducted for mediastinal (N2) metastasis to inform surgical planning.
• Preoperative evaluation included comprehensive imaging and clinical assessments to ensure accurate staging.

Clinical Implications

The development of a predictive nomogram can aid surgeons in identifying high-risk patients for lymph node metastasis, allowing for more tailored surgical approaches. This could lead to improved surgical outcomes and better management of early-stage peripheral NSCLC.

Conclusion

The study underscores the necessity of preoperative risk assessment in clinical stage IA NSCLC to optimize surgical strategies and enhance patient outcomes. Further validation of the nomogram is essential for clinical application.

References

1. A novel clinical framework for forecasting lymph node metastasis in T1 colorectal carcinoma, 2024 -- https://link.springer.com/article/10.1007/s00384-024-04621-y
2. Creation of Clinical Nomograms Utilizing PET/CT for Assessing Lymph Node Metastasis in Primary Lung Carcinoma, 2025 -- https://link.springer.com/article/10.1007/s00330-025-12166-z
3. Identifying Risk Factors for Lymph Node Metastasis in Early Colorectal Cancer: Development of a Predictive Nomogram and Risk Evaluation, 2024 -- https://link.springer.com/article/10.1007/s00384-024-04760-2
4. Management of Patients With Early-Stage Non-Small Cell Lung Cancer: An American College of Chest Physicians Clinical Practice Guideline -- https://www.sciencedirect.com/science/article/abs/pii/S0012369225007378
5. Patterns and preoperative risk factors of occult lymph node metastasis in clinical stage I lung cancer -- https://www.sciencedirect.com/science/article/abs/pii/S0169500225003538
6. The Journal of Clinical Endocrinology & Metabolism — Enhancing Recurrence Risk Assessment in Papillary Thyroid Cancer According to the 2015 ATA Guidelines
7. Management of Patients With Early-Stage Non-Small Cell Lung Cancer: An American College of Chest Physicians Clinical Practice Guideline - ScienceDirect
8. Frontiers | CALGB 140503 and the shift to sublobar resection for small, peripheral, node-negative NSCLC: historical context, secondary analyses, and next steps
9. Patterns and preoperative risk factors of occult lymph node metastasis in clinical stage I lung cancer - ScienceDirect